[Main] - [General Info] - [Symposia: 1 2 3 4 5 6] - [Posters] - [Registration] - [Committees] - [News]

Symposium II - - Thursday, May 7, 1998 - afternoon

Consensus Conference:
How should we assess atherosclerosis risk factors as we begin the "third millenium"?

Chair: David M. Goldberg
Co-Chair: Gerd Assmann

Sponsors: PARKE-DAVIS Pfizer


14:15 - 14:45h

High-density lipoprotein subclasses and apolipoprotein A-I

Jean-Charles Fruchart

Unité de Recherche sur les Lipoprotéines et l'Athérosclérose, Institut Pasteur de Lille, Lille, France


14:45 - 15:15h

Apolipoprotein B

Allan D. Sniderman

Director, Mike Rosenbloom Laboratory for Cardiovascular Research, McGill University, Montréal, Québec, Canada


15:15 - 15:45h

Apolipoprotein E

Jean Davignon

Director, Hyperlipidemia and Atherosclerosis Research Group, Clinical Research Institute of Montréal, Montréal, Québec, Canada


15:45 - 16:00h

Refreshments in the Poster Display Area, Campus Lobby, Medical Sciences Building
(just across from the entrance of the J.J.R. MacLeod Auditorium)


16:00 - 16:30h

Homocysteine

David E. C. Cole

Banting Institute, Department of Laboratory Medicine and Pathobiology,
University of Toronto, Toronto, Ontario, Canada


16:30 - 17:00h

High risk stategies for atherosclerosis

Gerd Assmann

Director, Institute for Arteriosclerosis Research, University of Münster, Münster, Germany


17:00 - 17:30h

Roundtable Discussion


[Main] - [General Info] - [Symposia: 1 2 3 4 5 6] - [Posters] - [Registration] - [Committees] - [News]

Version 3.2(21), revised May 10, 1998